Moreover, PepT1 holds considerable interest for pharmacologists in being a major route of entry for orally bioavailable compounds, such as the β-lactam antibiotics, angiotensin-converting enzyme inhibitors, antiviral and anti-cancer agents (reviewed in Terada & Inui 2004). Here, ACE is linked to cancer.